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A novel UDP-glucuronosyltransferase that conjugates bilirubin IXa. bilirubin monoglucuronide and an arylalkanoic acid was purified to homo- 
geneity from clolibrate treated Wistar rats. The enzyme displayed a subunit molecular mass of 54 kDa, a pl of 7.6 and was demonstrated to be 
N-g!ycusylated. Sequence analysis of peptidcs derived by endoproteinasc Glu-C cleavage of the purified enzyme indicated that it was a new member 
or the recently identified UGT/ subfamily. Immunoblot analysis demonstrated that this enzyme was absent from Ciunn rat liver. The moleculur 
derivation of this enzyme and the lack of it in Gunn rats is discussed. 
UGT; subfamily: Arylalkanoic acid; Cilycosylation; Congenital jaundice; Acylglucuronidc 
1. INTRODUCTION 
UDP-glucuronosyltransferases (UDPCiTs, EC 
2.4.1. I?) are a family of isoenzymes which are re- 
sponsible for the glucuronic acid conjugation of poten- 
tially toxic xenobiotic and endogenous compounds al- 
lowing their excretion in bile and urine [l]. 
aberrations in bilirubin excretion and due to it catalys- 
ing the formation of acylglucuronides which have been 
implicated in toxic drug reactions [6]. Here we report 
the isolation and biochemical analysis of this enzyme 
which represents a second bilirubin UDPGT in rat liver 
and discuss the molecular basis for its absence in the 
mutant Gunn rat. 
Biliruhin UDPGT activity performs the critical func- 
tion of catalysing the glucuronidation of bilirubin IXa, 
the toxic end product of haem catabolism thereby faci- 
litating its safe elimination from the body [l]. Jaundice 
(hyperbilirubinaellqia) caused by the genetic deficiency 
of this enzyme activity has been demonstrated to result 
in serious physiological consequences that can lead to 
death [l]. Indirect evidence such as the additive inher- 
itance of bilirubin UDPGT inducibility in mice [2] and 
the two peaks of bilirubin UDPGT activity observed by 
chromatoibcusing soiubilised microsomes [3] have indi- 
cated the existence of more than one bilirubin UDPGT 
in rodents. Recently a short communication describing 
a rat bilirubin UDPGT cDNA has appeared [4]. In our 
laboratory we have previously reported the existence of 
a UDPGT that mediates the glucuronidation of bili- 
rubin and arylalkanoic acids, which was absent from 
congeni,tally jaundiced Gunn rats [S], Analysis of this 
transferase is important due to the possible toxicologi- 
cal consequences of avjlcarboxylic acids causing 
A preliminary communication of this study was 
reported previously [7]. 
2. MATERIALS AND METHODS 
Bilirubin. UDP-glucuronic acid (ammonium salt), Nitro blue tetra- 
zolium. Sbbromo&chloro-3-indoyl phosphate and alkaline phosphat- 
ase-conjugated rabbit anti-goat IgG were all obtained from Sigma 
(Poole, UK’). Ethylanthranilate wus from Kodak (Rochester. NY). 
Nitrocellulose was obtained from Andcrman (Kingston-upcm- 
Thames. Surrey, UK). Bovine serum albumin fraction V and glyco- 
peptide N-glycosidase F were from Bwhringer Mannhuim (Sussex, 
UK), 
Egg yolk phosphatidylcholinc was from Lipid !“roducts (Surrey, 
UK). Lubrol 12A9 was from ICI Organics Division (Manchester, 
UK). Ultrafiltration apparatus was from Amicon (Gloucestershire, 
UK). Mono P HR5/20 columns, Polybuffcr 96. Q-Sepharose fast Bow, 
Sephactyl S-300, Sephadex G25M PDIO columns and FPLC system 
were from Pharmacia (Milton Keynes, UK). All other chemicals were 
of analytical grade from Merck (Poole, UK). 
2.2. Anitrtuls 
Corrwpondetrce address: D.J. Clarke, Department ofBiochemical Me- 
dicine, Univrrsiry nf Dundee, Ninewells Hospital and Medical School, 
Dundee, DDI 9SY, IJK. Fax: (44) (382) Cirl4bZO. 
Wistar and Gunn rats were from the colonies maintained at the 
Animsl Unit, ,Ninewells Hospital and Medical *hoot* Dtmdee. 
2.3. Br:yntc ussaw ott~l protein drwrntinurion 
Bilimbin and 7,7,7-tripheaylheptanoic acid g!ucuronidation were 
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measured as previously dcslzribed [5]. HPLC analysis of bilirubin con- 
jllgates was by the method of Odell et al. [8]. Phosphatidylcholinc 
reconstitution of purified UDPGT fractions was as described in [Y], 
Protein content of microsomal samples was determined by the 
method of Lowry et al. [IO] and in purified fractions by the Bradford 
method [I I] using bovi:ie serum albumin as standard. 
2.4, Elecrrophrusis uttd itrttnunobior undysis 
Sodium dodecyl sulphate polyacrylamidc gel electrophorcsis (SDS- 
PAGE) and immunoblot analysis using an alkaline phosphatase 
linked detection system were carried out as described previously [I?]. 
The production anti characterization of anti-rat liver UDPGT 
(RAL I), anti-rat kidney bilirubin/phcnol UDPGT (RAKI) and anti- 
rat testosterone UDPGT antibodies have been described elsewhere 
[13-151. 
2.5. Large scale ptrriJcniiut of bilirukitt UDPGT (pl 7.6) 
Solubilised microsomal fractions isolated from the livers of 25-30 
male Wistar rats (200-300 g) pretreated with clofibmte were used for 
the preparation of a D-606 ammonium sulphate precipitated micro- 
somal fraction as previously described [S]. The fnal ammonium 
sulphate precipitate was dissolved in and extensively dialyscd against 
20 mM Tris-HCI, pH 6.0, 0.05% w/v Lubrol PX. 5 mM mercaptoe- 
thanol, 5% v/v glycerol (buffer A). The resultant fraction was then 
subjected to FPLC anion-exchange chromatography using a high- 
f3lpaCity Q-Sepharose fast-flow and a Pharmacia XK column (5x50 
cm) at 200 ml/h. Bilirubin UDPGT activity was eluted from the col- 
umn using a 4 litre linear gradient ofO-O.4 M KCI in buirer A. This 
allowed the partial resolution ofbilirubin UDPGTactivity from other 
UDPGT activities producing a similar clution profile to that previ- 
ously obtained with DEAE cellulose [5] but greatly increasing the 
yield. Selected fractions were concentrated and applied to a Sephacryl 
S-300 column (I 5x66 cm) in buffer A with 0.1 M NaCl and bilirubin 
UDPGI’ activity eluted at a flow rate of IO ml/h. Bilirubin UDPGT 
enriched fractions from the gel filtration step were applied to a Mono 
P chromatofocusing column fitted to an FPLC system and a pH 
gradient of 9.0-6.0 over 35 ml was generated according to the manu- 
facturer’s instructions (Pharmacia) with the inclusion of 0.05% w/v 
Lubrol PX, 5 mM 2.mercaptoethanol, 5% v/v glycerol in the buffers. 
Buffer A was 74 mM Tris-Cl pH 9.3. Buffer B was 10% polybufferY6 
pH 6.0. 
2.6. Deglyosyiuriott with pepride N-g/_wosirfase F 
The purified protein (2 ,ug) was incubated with 2 U of peptide 
N-glycosidase F (EC 3.2.2.18) as previously described [ 161 in the pres- 
ence of 10 mM I,lO-o-phcnanthrolinc for 18 h at 37°C. 
2.7. Preparurion of pepprides rrttrf scqrrcwcr crtrril_d~ 
The purified enzyme was fragmented with Srup/~~lococcus NIII’L’IIS 
endoprotcinase Glu-C using conditions that generated a relatively 
small number (~15) of large ftagmenls (IO-30 kDa) (0.05% SDS, 53 
mM sodium phosphate pH 7.0. at a protease/protein substrate ratio 
of 0.3 al 18°C for 4 II). Cleaved peptides were purtfied by electroelu- 
tion from Tricine gels [I 7. IS]. The puriRcd protein: and derived peptide 
fragments were prepared and coupled via their N-terminus and lysyl 
side chains to p-phenylcnc diiosothiocyanate activated glass and sc- 
quenccd by automated solid-phase Edman degradation essentially as 
described by Findlay el al, [IS]. 
3, RESULTS AND DISCUSSION 
3.1. Enzynte isolation and characterizution 
FPLC chromatography of bilirubin UDPGT activity 
from ammonium sulphate fractionated microsomes by 
anion exchange and gel filtration led to a 20-fold pu- 
rification of the activity (Table I). Chromatofocusing of 
the high activity fractions from the gel filtration step led 
to a major peak of bilirubin UDPGT activity eluting at 
pH 7.6. The specific activity of the purified preparation 
towards bilirubin and 7,7,7-triphenylheptanoic acid was 
I IO-142 nmol/min/mg and 63-75 nmol/min/mg, (three 
preparations), respectively, representing a 129-fold pu- 
rification over ammonium sulphate fractionated micro- 
somes (Table I). HPLC analysis of bilirubin glucu- 
ronides formed by this enzyme indicated it was capable 
of both mono- and diglucuronidation of bilirubin (not 
shown). 
On SDS-PAGE analysis of fractions corresponding 
to the pI 7.6 peak a single polypeptide of molecular 
mass 54 kDa was apparent (Fig. la). Incubation of this 
preparation with an enzyme that catalyses the cleavage 
of oligosaccharide moieties from N-linked glyco- 
proteins caused a decrease in the apparent molecular 
mass of the protein of 2 kDa, (Fig. la) indicating it was 
a glycoprotein. The protein was immunoreactive to an 
antibody (RAKl) raised to phenol and bilirubin 
UDPGTs but not to one raised to testosterone UDPGT 
(not shown). 
3.2. Luck of enzyme expression in Chn rat iiser 
Previously we have demonstrated that the reactions 
catalysed by this purified enzyme were absent from con- 
genitally jaundiced Gunn rat liver microsomes [5]. Im- 
munoblot analysis with a broad specificity anti- 
UDPGT antibody (RALI) indicated that there was no 
Table I 
Purification of hepatic bilirubin UDPGT (PI 7.6) from Wistar rats 
Fraction 
(NH&SO, fractionated 
microsomcs 
Q-Scpharose FF chromatography 
Sephticryl S-300 chromatography 
Chromatofocusing 
Total 
protein 
(mg) 
5148 
175 
63.2 
I .94 
Specific 
activity 
(U”/mB) 
I.1 
13.9 
22.4 
142 
Total 
activity 
(U’) 
5662 
2433 
1416 
275.5 
Yield 
46 
100 
43 
25 
4.9 
Purification 
factor 
I:6 
2014 
129 
*l U represents I nmol of bilirubin glucuronide formed per min of incubation, Data were from a single representative 
experiment. 
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Fig. 1. Molecular analysis of the purified UDPGT and its absence in 
Gunn rats. (a) SDS-PAGE of the purified UDPGT and evidence of 
glycosylation. Lane I, protein mo!ecular weight standards: albumin 
(68 kDa), pyruvate kinase (57 kDa), fumarase (49 kDa) and aldolase 
(40 kDa); lane 2, 20 pg of Wistar rat liver microsomal protein; lane 
3,2 ~6 of purified bilirubin UDPGT; lane 4,2 /~g of purilicd bilirubin 
UDPGT treated with glycopeptidase-V-glycosidase F as described in 
section 2, Proteins were visualized using Coomassie blue. (b) Immu- 
noblot analysis of liver microsames prepared from Wistar and Gunn 
rats and the purified WDPGT. Lane I. 20 pg of Wistnr rat liver 
microsomal proteins: lane 2, 20 !g of Gunn rat liver microsomal 
proteins; lane 3, OS ,ug of purilicd bilirubin UDPGT. The relative 
mobilities of molecular weight marker proteins in kDa, as determined 
on an identical Coomassie blue-stained gel run at the same time, are 
shown on the right. 
immunoreactive protein in Gunn rat liver isolate that 
co-migrated with the purified protein in contrast to 
Wistar rat extracts (Fig. lb). Thus the lack of enzyme 
activity towards 7,7,7-triphenylheptanoic acid and bili- 
rubin appeared to be due to the absence of expression 
of this UDPGT isoenzyme. 
3.3. Evidence fbr ihe existence of’ u secortd bilirubin 
To determine whether or not this was the same bili- 
rubin UDPGT that was cloned by Sato et al. [4] we 
peptides with deduced amino acid sequences of rat 
UDPGT cDNAs indicated that a novel bilirubin 
prepared. peptides for microsequence analysis. Sequenc- 
ing of the native 54 kDa protein indicated that the 
UDPGT had been isolated (Fig. 2). The 12,26.5 and 54 
sample was homogeneoxi as there was cleavage of only 
kDa poptide sequences were most identical with a 
cloned truman 
one amino acid per Edman degradation cycle. Compar- 
SIlirubin UDPGT (HUG-Rrl) (Fig. 2) 
ison of this N-terminal sequence and amino acid se- 
The residues identified in the 14 and 28 kDa peptides 
quences derived from endoproteinase Glu-C cleavage 
were identical with rat enitrophenol UDPGT and the 
other rat bilirubin UDPGT (Fig. 2) indicating that this 
h 
34kDa pepMa 
$~~psPUt+e 
4ljP3T 
HUG&i 
!+JGBR 
RLUG 38 
A-‘18 
a 
26,SkDa pplide 
i%T 
HUG-Brl 
HUGBR 
RLUG 38 
A-18 
C. 
13kDa peptide 
%b 
HUG-Brl 
HUG-En? 
!%G38 
D. 
2BhDa psptlde a 
2BkDapeptide b 
!%&T 
I! 
E 
A-W 
1 
1 
26 
26 
28 
29 
24 
30 
XKLLVIPIDGSHWL 14 
XKLLVIP 7 
G.v..f.me..... 39 
D....v.Q...... 39 
G.i.l..V...... 41 
G.v..v.T...P.. 42 
G.v..W.nmF...m 37 
G............. 43 
1 
66 
66 
70 
z 
12 
XXFYTNRKYPVXFQNEXVXAXF 22 
GED.~.IqT.aFPyTK.BYPRRI 90 
. ..P..R.D.KES. 92 
EEK.f .lTA.a.PwTqKRFDRVT 93 
KSPD.KPETf .TSVSKdRlENY. 90 
EGS.........P.... N.T.A. 94 
1 
160 
176 
182 
183 
La2 
185 
XTQXPAPLSYVPF%LXXNXXXMNP 
EA..C.L.S..I.&.THLSDR.T. 
NIG.S.~.V....L-FYT~SDNIT. 
EA..C.N.f....rP.SSHSDR.T. 
KG..C.N.S..1..L.!lT.SDEl.T. 
SSGrFIL.P....VI.SGMGGP.T. 
EA..C.........S.SS.TDR... 
a 
1 
207 
205 
209 
290 
292 
290 
FEAYVNASGEHGIXXPXL 
A~~GEHXIVXFXLXXM 
E..............V.S.GS. 
E..............V.S.GS. 
i ....... ..V.S.GS. 
f::::i.........V.S.GS. 
dM.Df.qs.....v.V.S.GS. 
E.. .......... ..V.S.GS. 
1 XRXXXXTLNVLRMXXDXLXXA 
403 ET.GAGV.......TA.D.EN. 
401 ET.GAGV.......TA.D.EN. 
405 RTkGAGV ..... ..TSeD.EN. 
406 ETkGAGV.......TSeD.EN. 
400 VHkGAAV.. . iRT.SKSD.FN. 
406 ET.GAGV.. . . .K+ 416 
ia 
19 
306 
306 
310 
321 
313 
311 
91 
424 
422 
426 
427 
429 
24 
204 
202 
206 
207 
206 
209 
Fig. 2. Sequences of bilirubin UDPGT (pl 7.6) pptidm and their 
homology with dcduccd amino acid sequences from UDPGTcDNAs. 
Sequence data from the bilirubin UDPGT pcptides were aligned with 
similar regions of other UDPCiTs. pSK1, rat bilirubin UDPGT 141; 
4NPCiT. rat 4-nitrophcnol UDPGT 1191; HUG-Brl, HUG-Br2, 
human bilirubin UDPGTs [20]; RLUG38, rat testosterone UDPGT 
[2l]; A-l%truncated mutant Gunn rat UDPGT [22]. Two amino acids 
at the same positian in the pptide’s sequence denote two potiiblc 
assignments derived from microsequence analysis, Numbers at the 
N-terminal and C-terminal of sequences denote positions from the 
amino terminal amino acid in the respective protein sequences. Idcnti- 
cal residues with thd bilirubin UDPGT (~17.6) peptides arc indicated 
by a dot (a). Conservative replaecmcnts [23J arc denoted by the lower 
case letter eprescntinp the particular amino acid, whereas more radi- 
cal changes are shown in upper case. N-Linked glyeosylation con- 
sensus equences are underlined. The * indicates the relative position 
of the stop codon in the A-18 cDNA sequence. 
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transferase belongs to the recently identilied UGTi sub- 
family of UDPGTs that share identical C-terminal 
domains [24]. 
It was noteworthy that the amino-terminal residue of 
the native purified protein corresponded to the 2&30th 
residue of the cDNA derived protein sequences (Fig. 2). 
This suggested that like 4-nitrophenol UDPGT [19] and 
testosterone UDPGT [2 I] a signal pcptide was removed 
during the biogenesis of this enzyme. Interestingly, the 
residues identified in the overlapping 28 kDa peptides 
contained an N-linked glycosylation consensus se- 
quence Asn-Ala-Ser (Fig. 2) [25] with an asparagine 
HPLC elution profile characteristic of oligosaccharide 
modified asparagincs inother glycoproteins (I&en, J.N. 
and Findlay, J.B.C., unpublished work). 
Gunn ruts 
Whilst this manuscript was being prepared a very 
recent report by Iyanagi [22] described 3 new subfamily 
UGTI cDNAs from the Gunn rat with a 3’-terminal 
half identical to a mutant non-functional Gunn rat 
phenol UDPGT previously identified [26] (Fig. 2). The 
homologues of these new cDNAs iz ‘normal’ rats have 
not been identified nor the function of the proteins they 
encode assigned. 
Comparison of the partial amino acid sequences of 
the new bilirubin UDPGT presented in this paper with 
lyanagi’s sequences indicated that all but the 14 kDa 
peptide sequence were identical with the deduced pro- 
tein sequence of the Gunn rat A-18 cDNA (Fig. 2). The 
non-identical sequence corresponded to the site of the 
proposed mutation that would result in a truncated 
Gunn rat UDPGT protein [22,26] (Fig. 2). 
It therefore appears likely that this mutation was the 
cause of the absence of this enzyme from Gunn rats. 
4. CONCLUDING REMARKS 
This study has demonstrated that a second bilirubin 
UDPGT exists in ra:s which belongs to the recently 
identified CJGTI subfamily, the members of which have 
been proposed to be produced via alternative splicing 
of a common transcript [24]. The lack of this and at least 
a further 4 UGT1 gene subfamily members in Gun11 rats 
[22] (Fig. 1) suggests that a single genetic mutation in 
these animals results in the loss of several UDPGT 
proteins. 
The high identity of the new rat isoform reported here 
to a human bilirubin UDPGT (HUG-&l.) suggest hat 
this isoform may mediate toxic acylglucuronide forma- 
tion in man. 
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